You have 9 free searches left this month | to do more

adavosertib

Adavosertib is a drug used to treat Advanced Malignant Solid Neoplasm, Recurrent Ovarian Carcinoma, Cervical Carcinoma, and other conditions. Adavosertib is being actively studied in 19 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)M D Anderson Cancer Center
AstraZenecaUniversity of Pittsburgh Cancer Institute (UPCI)
M.D. Anderson Cancer CenterDana-Farber Cancer Institute
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Active, not recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • New Haven, Connecticut
  • +13 more
2021-11-19
Nov 19, 2021
A
Recruiting
  • Advanced Solid Tumours
  • Adavosertib
  • +3 more
  • New Haven, Connecticut
  • +11 more
2021-11-19
Nov 19, 2021
A
Active, not recruiting
  • Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
  • Adavosertib
  • +4 more
  • Tucson, Arizona
  • +18 more
2021-10-07
Oct 7, 2021
M
Recruiting
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
2020-06-24
Jun 24, 2020
A
Active, not recruiting
  • Uterine Serous Carcinoma
  • Adavosertib
  • Birmingham, Alabama
  • +41 more
2021-11-30
Nov 30, 2021
N
Active, not recruiting
  • Anaplastic Astrocytoma
  • +5 more
  • Adavosertib
  • +3 more
  • Birmingham, Alabama
  • +23 more
2021-11-30
Nov 30, 2021
N
Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Adavosertib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
2021-07-02
Jul 2, 2021
M
Recruiting
  • Advanced Fallopian Tube Carcinoma
  • +21 more
  • Adavosertib
  • Laboratory Biomarker Analysis
  • Houston, Texas
  • +6 more
2020-07-13
Jul 13, 2020
N
Active, not recruiting
  • Central Nervous System Embryonal Tumor With Rhabdoid Features
  • +14 more
  • Adavosertib
  • Irinotecan Hydrochloride
  • Birmingham, Alabama
  • +23 more
2021-09-15
Sep 15, 2021
N
Active, not recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Adavosertib
  • +2 more
  • Birmingham, Alabama
  • +11 more
2021-08-12
Aug 12, 2021
N
Suspended
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Adavosertib
  • Duarte, California
  • +8 more
2021-10-01
Oct 1, 2021
N
Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • Adavosertib
  • +5 more
  • Aurora, Colorado
  • +7 more
2021-05-06
May 6, 2021
C
Recruiting
  • Prostate Cancer
  • Adavosertib
  • +6 more
  • Edmonton, Alberta, Canada
  • +11 more
2021-07-13
Jul 13, 2021
N
Recruiting
  • Clinical Stage III Esophageal Adenocarcinoma AJCC v8
  • +58 more
  • Adavosertib
  • Radiation Therapy
  • Duarte, California
  • +6 more
2021-11-03
Nov 3, 2021
N
Recruiting
  • Clear Cell Renal Cell Carcinoma
  • +6 more
  • Adavosertib
  • Orange, California
  • +28 more
2021-12-01
Dec 1, 2021
N
Active, not recruiting
  • Cervical Carcinoma
  • +23 more
  • Adavosertib
  • +2 more
  • Sacramento, California
  • +7 more
2021-11-09
Nov 9, 2021
N
Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Adavosertib
  • +5 more
  • Duarte, California
  • +14 more
2021-11-18
Nov 18, 2021
N
Terminated
  • Acute Myeloid Leukemia
  • +10 more
  • Adavosertib
  • +3 more
  • Tampa, Florida
  • +1 more
2018-05-24
May 24, 2018
N
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Adavosertib
  • +33 more
  • Birmingham, Alabama
  • +1383 more
2021-12-01
Dec 1, 2021